Healthcare provider profile · identity verified

Dilipkumar M Bera, MD

Internal Medicine · PHILLIPSBURG, NJ · NPI 1700823853

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	635	207
Levothyroxine Sodium	Levothyroxine Sodium	388	113
Amlodipine Besylate	Amlodipine Besylate	338	114
Metformin Hcl	Metformin Hcl	302	89
Lisinopril	Lisinopril	291	83
Albuterol Sulfate Hfa	Albuterol Sulfate	262	69
Pantoprazole Sodium	Pantoprazole Sodium	255	66
Carvedilol	Carvedilol	254	73
Losartan Potassium	Losartan Potassium	225	70
Alprazolam	Alprazolam	222	55
Gabapentin	Gabapentin	197	61
Fluticasone Propionate	Fluticasone Propionate	186	73
Methylprednisolone	Methylprednisolone	160	116
Montelukast Sodium	Montelukast Sodium	156	40
Duloxetine Hcl	Duloxetine Hcl	152	30
Eliquis	Apixaban	152	33
Metoprolol Tartrate	Metoprolol Tartrate	145	38
Omeprazole	Omeprazole	140	43
Escitalopram Oxalate	Escitalopram Oxalate	137	37
Metoprolol Succinate	Metoprolol Succinate	137	51
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	137	21
Tamsulosin Hcl	Tamsulosin Hcl	133	37
Furosemide	Furosemide	130	42
Famotidine	Famotidine	121	41
Glimepiride	Glimepiride	105	30
Simvastatin	Simvastatin	105	32
Clopidogrel	Clopidogrel Bisulfate	97	29
Zolpidem Tartrate	Zolpidem Tartrate	94	17
Azithromycin	Azithromycin	92	79
Potassium Chloride	Potassium Chloride	88	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	83	14
Tramadol Hcl	Tramadol Hcl	83	24
Allopurinol	Allopurinol	81	19
Rosuvastatin Calcium	Rosuvastatin Calcium	81	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	79	20
Meloxicam	Meloxicam	79	33
Jardiance	Empagliflozin	74	17
Atenolol	Atenolol	71	19
Mirtazapine	Mirtazapine	70	17
Clonidine Hcl	Clonidine Hcl	69	18
Pravastatin Sodium	Pravastatin Sodium	68	26
Sertraline Hcl	Sertraline Hcl	67	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	63	22
Ondansetron Odt	Ondansetron	60	suppressed
Trazodone Hcl	Trazodone Hcl	60	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	28
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	55	suppressed
Breo Ellipta	Fluticasone/Vilanterol	53	18
Ibuprofen	Ibuprofen	53	20
Citalopram Hbr	Citalopram Hydrobromide	51	13
Ozempic	Semaglutide	51	11
Celecoxib	Celecoxib	50	17
Pregabalin	Pregabalin	50	12
Torsemide	Torsemide	49	17
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	48	16
Farxiga	Dapagliflozin Propanediol	47	suppressed
Repaglinide	Repaglinide	47	16
Buspirone Hcl	Buspirone Hcl	44	12
Baclofen	Baclofen	43	13
Metformin Hcl Er	Metformin Hcl	43	15
Levofloxacin	Levofloxacin	41	31
Ciprofloxacin Hcl	Ciprofloxacin Hcl	40	31
Symbicort	Budesonide/Formoterol Fumarate	39	suppressed
Synthroid	Levothyroxine Sodium	39	12
Trulicity	Dulaglutide	38	suppressed
Amoxicillin	Amoxicillin	37	21
Hydroxyzine Hcl	Hydroxyzine Hcl	37	12
Prednisone	Prednisone	37	20
Hydrochlorothiazide	Hydrochlorothiazide	36	16
Venlafaxine Hcl Er	Venlafaxine Hcl	36	11
Ondansetron Hcl	Ondansetron Hcl	35	20
Cephalexin	Cephalexin	33	27
Spironolactone	Spironolactone	32	14
Ezetimibe	Ezetimibe	31	11
Januvia	Sitagliptin Phosphate	31	suppressed
Lorazepam	Lorazepam	31	11
Meclizine Hcl	Meclizine Hcl	31	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	30	12
Linzess	Linaclotide	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Hydrocortisone	Hydrocortisone	28	19
Nifedipine Er	Nifedipine	28	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	27	suppressed
Fenofibrate	Fenofibrate,micronized	27	suppressed
Methocarbamol	Methocarbamol	27	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Fosinopril Sodium	Fosinopril Sodium	25	suppressed
Klor-Con M20	Potassium Chloride	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Ibandronate Sodium	Ibandronate Sodium	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Nystatin	Nystatin	23	11
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	12
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Cefuroxime	Cefuroxime Axetil	20	19
Diazepam	Diazepam	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Valsartan	Valsartan	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Verapamil Sr	Verapamil Hcl	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Clonazepam	Clonazepam	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Pen Needle	Pen Needle, Diabetic	17	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	17	suppressed
Topiramate	Topiramate	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Colchicine	Colchicine	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Naproxen	Naproxen	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Ramipril	Ramipril	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	14	suppressed
Gemtesa	Vibegron	14	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Finasteride	Finasteride	12	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	12	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Icosapent Ethyl	Icosapent Ethyl	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nuvigil	Armodafinil	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Niacin Er	Niacin	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error